| 1 |
33572981 | Effects of Subchronic Administrations of Vortioxetine, Lurasidone, and Escitalopram on Thalamocortical Glutamatergic Transmission Associated with Serotonin 5-HT7 Receptor. | 2021 Jan 29 |
2 |
| 2 |
33587394 | Efficacy of Vortioxetine Monotherapy for Posttraumatic Stress Disorder: A Randomized, Placebo-Controlled Trial. | 2021 Mar-Apr 01 |
1 |
| 3 |
31678343 | Effects of Vortioxetine and Escitalopram on Electroencephalographic Recordings - A Randomized, Crossover Trial in Healthy Males. | 2020 Jan 1 |
1 |
| 4 |
32750222 | Vortioxetine induces apoptosis and autophagy of gastric cancer AGS cells via the PI3K/AKT pathway. | 2020 Oct |
2 |
| 5 |
30194544 | Other Antidepressants. | 2019 |
1 |
| 6 |
30317998 | QSAR Analysis of Multimodal Antidepressants Vortioxetine Analogs Using Physicochemical Descriptors and MLR Modeling. | 2019 |
1 |
| 7 |
30457395 | Vortioxetine: a novel antidepressant for the treatment of major depressive disorder. | 2019 Jan |
3 |
| 8 |
31835640 | Vortioxetine Subchronically Activates Serotonergic Transmission via Desensitization of Serotonin 5-HT1A Receptor with 5-HT3 Receptor Inhibition in Rats. | 2019 Dec 10 |
2 |
| 9 |
29189941 | Vortioxetine: Clinical Pharmacokinetics and Drug Interactions. | 2018 Jun |
1 |
| 10 |
28677828 | Vortioxetine for depression in adults. | 2017 Jul 5 |
1 |
| 11 |
28692076 | [Full functional recovery in depression treatment. Clinical cases treated with vortioxetina]. | 2017 May-Jun |
2 |
| 12 |
26702943 | Vortioxetine promotes maturation of dendritic spines in vitro: A comparative study in hippocampal cultures. | 2016 Apr |
1 |
| 13 |
27996982 | [Vortioxetine in the treatment of major depression]. | 2016 Nov-Dec |
2 |
| 14 |
25016186 | Vortioxetine, a novel antidepressant with multimodal activity: review of preclinical and clinical data. | 2015 Jan |
1 |
| 15 |
26035185 | A randomized, double-blind, placebo-controlled study of the efficacy and safety of vortioxetine 10 mg and 20 mg in adults with major depressive disorder. | 2015 May |
1 |
| 16 |
26035186 | A randomized, double-blind, placebo-controlled study of the efficacy and safety of 2 doses of vortioxetine in adults with major depressive disorder. | 2015 May |
1 |
| 17 |
26174134 | Differentiated effects of the multimodal antidepressant vortioxetine on sleep architecture: Part 2, pharmacological interactions in rodents suggest a role of serotonin-3 receptor antagonism. | 2015 Oct |
1 |
| 18 |
26253622 | Differentiated effects of the multimodal antidepressant vortioxetine on sleep architecture: Part 1, a pharmacokinetic/pharmacodynamic comparison with paroxetine in healthy men. | 2015 Oct |
1 |
| 19 |
26389667 | Binding of the multimodal antidepressant drug vortioxetine to the human serotonin transporter. | 2015 Nov 18 |
5 |
| 20 |
24165478 | Vortioxetine for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed? | 2014 Jan |
1 |
| 21 |
24570588 | New generation multi-modal antidepressants: focus on vortioxetine for major depressive disorder. | 2014 |
1 |
| 22 |
25075188 | Pharmacology and clinical potential of vortioxetine in the treatment of major depressive disorder. | 2014 |
2 |
| 23 |
23428337 | 5-HTT and 5-HT(1A) receptor occupancy of the novel substance vortioxetine (Lu AA21004). A PET study in control subjects. | 2013 Oct |
1 |